ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MARIA WISCOVITCH M.D.

GENERAL VALERO AVENUE HOSP. HIMA-SAN PABLO-FAJARDO, 1ST FLOOR, NEUROLOGIA

Fajardo | Puerto Rico | 00738

(787) 655-0505

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,286Medicare Part D Prescriptions Filled, Including Refills
$722K Total Retail Price of All Prescriptions
1,014 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
GABAPENTIN 1,075 771
DONEPEZIL HCL 851 775
NAMENDA 690 646
BACLOFEN 571 295
EXELON 283 269
DIVALPROEX SODIUM ER 258 157
TOPIRAMATE 257 63
CARBIDOPA-LEVODOPA 246 233
LYRICA 234 76
PRAMIPEXOLE DIHYDROCHLORIDE 204 168
TRIHEXYPHENIDYL HCL 182 163 R
PRIMIDONE 174 140
RIVASTIGMINE 147 131
TIZANIDINE HCL 143 63
TRAMADOL HCL 134 71
CYMBALTA 130 85
LEVETIRACETAM 124 24
AMITRIPTYLINE HCL 123 62 R
FLECTOR 123 55
VITAMIN B-12 122 102
VOLTAREN 120 82
TRAMADOL HCL-ACETAMINOPHEN 116 79
ASPIRIN EC 98 83
RANITIDINE HCL 92 67
CLOPIDOGREL 88 69
VENLAFAXINE HCL ER 88 86
AMANTADINE 78 61
SIMVASTATIN 78 55
OXCARBAZEPINE 77 43
MECLIZINE HCL 67 46
MULTIVITAMINS 65 65
ARICEPT 64 54
PLAVIX 63 44
STALEVO 100 57 57
PAROXETINE HCL 53 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.